Literature DB >> 11222467

Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study.

S Kiechl1, G Egger, M Mayr, C J Wiedermann, E Bonora, F Oberhollenzer, M Muggeo, Q Xu, G Wick, W Poewe, J Willeit.   

Abstract

BACKGROUND: Chronic infections have been implicated in the pathogenesis of atherosclerosis, yet from an epidemiological perspective, this concept remains controversial. METHODS AND
RESULTS: The Bruneck Study is a prospective population-based survey on the pathogenesis of atherosclerosis. In 826 men and women 40 to 79 years old (1990 baseline), 5-year changes in carotid atherosclerosis were thoroughly assessed by high-resolution duplex scanning. The presence of chronic respiratory, urinary tract, dental, and other infections was ascertained by standard diagnostic criteria. Chronic infections amplified the risk of atherosclerosis development in the carotid arteries. The association was most pronounced in subjects free of carotid atherosclerosis at baseline (age-/sex-adjusted odds ratio [95% CI] for any chronic infection versus none, 4.08 [2.42 to 6.85]; P:<0.0001) and applied to all types of chronic (bacterial) infections. It remained independently significant after adjustment for classic vascular risk attributes and extended to low-risk individuals free of conventional risk factors. Among subjects with chronic infections, atherosclerosis risk was highest in those with a prominent inflammatory response. Markers of systemic inflammation, such as soluble adhesion molecules and circulating bacterial endotoxin, and levels of soluble human heat-shock protein 60 and antibodies to mycobacterial heat-shock protein 65 were elevated in subjects with chronic infections and predictive of an increased risk of atherosclerosis.
CONCLUSIONS: The present study provides solid evidence for a role of common chronic infections in human atherogenesis. Induction of systemic inflammation and autoimmunity may be potential pathophysiological links.

Entities:  

Mesh:

Year:  2001        PMID: 11222467     DOI: 10.1161/01.cir.103.8.1064

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  138 in total

1.  Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study.

Authors:  K A Forde; K Haynes; A B Troxel; S Trooskin; M T Osterman; S E Kimmel; J D Lewis; V Lo Re
Journal:  J Viral Hepat       Date:  2011-11-13       Impact factor: 3.728

2.  Relationship between periodontal disease, tooth loss, and carotid artery plaque: the Oral Infections and Vascular Disease Epidemiology Study (INVEST).

Authors:  Moïse Desvarieux; Ryan T Demmer; Tatjana Rundek; Bernadette Boden-Albala; David R Jacobs; Panos N Papapanou; Ralph L Sacco
Journal:  Stroke       Date:  2003-07-31       Impact factor: 7.914

3.  Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells.

Authors:  Lynn L Stoll; Gerene M Denning; Wei-Gen Li; James B Rice; Allan L Harrelson; Sara A Romig; Skuli T Gunnlaugsson; Francis J Miller; Neal L Weintraub
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

4.  Evidence for association between hepatitis C virus seropositivity and coronary artery disease.

Authors:  C Vassalle; S Masini; F Bianchi; G C Zucchelli
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

5.  The incidence of infectious diseases and changes in the mortality of atherosclerosis-related complications in the Czech population over the past two decades.

Authors:  Alena Dvorakova; Rudolf Poledne
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

6.  Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data.

Authors:  Matthias W Lorenz; Joseph F Polak; Maryam Kavousi; Ellisiv B Mathiesen; Henry Völzke; Tomi-Pekka Tuomainen; Dirk Sander; Matthieu Plichart; Alberico L Catapano; Christine M Robertson; Stefan Kiechl; Tatjana Rundek; Moïse Desvarieux; Lars Lind; Caroline Schmid; Pronabesh DasMahapatra; Lu Gao; Kathrin Ziegelbauer; Michiel L Bots; Simon G Thompson
Journal:  Lancet       Date:  2012-04-27       Impact factor: 79.321

Review 7.  Assessing cardiovascular risk in hepatitis C: An unmet need.

Authors:  Javier Ampuero; Manuel Romero-Gómez
Journal:  World J Hepatol       Date:  2015-09-08

8.  A Novel ASK Inhibitor AGI-1067 Inhibits TLR-4-Mediated Activation of ASK1 by Preventing Dissociation of Thioredoxin from ASK1.

Authors:  Shuhui Zheng; Lingli Long; Yonghao Li; Yuxia Xu; Zhang Jiqin; Weidong Ji; Wang Min
Journal:  Cardiovasc Pharm Open Access       Date:  2015-02-26

9.  Increased titres of anti-human heat shock protein 60 predict an adverse one year prognosis in patients with acute cardiac chest pain.

Authors:  D H Birnie; L E Vickers; W S Hillis; J Norrie; S M Cobbe
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

10.  Respiratory disease and cardiovascular morbidity.

Authors:  R-S Koskela; P Mutanen; J-A Sorsa; M Klockars
Journal:  Occup Environ Med       Date:  2005-09       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.